Effects of OROS® methylphenidate (MPH) treatment on behavior and performance in children with ADHD with and without comorbid learning disability

被引：0
|
作者：
Starr, H. Lynn [1 ]
Armstrong, Robert [1 ]
Damaraju, C., V [2 ]
Ascher, Steve [2 ]
机构：
[1] Johnson & Johnson, Psychiat, New Brunswick, NJ USA
[2] Johnson & Johnson, Biostat, New Brunswick, NJ USA
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2011年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
P01-36
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [21] Differences and similarities in pharmacological treatment outcomes between children and adolescents with ADHD transitioning onto OROS MPH
    Schaeuble, Barbara
    Berek, Michael
    Kordon, Andreas
    Mattejat, Fritz
    Rettig, Klaus
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S131 - S131
  • [22] Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: Main and incremental effects across settings
    Kolko, DJ
    Bukstein, OG
    Barron, J
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (05) : 578 - 586
  • [23] A preliminary study on the effect of methylphenidate on motor performance in children with comorbid DCD and ADHD
    Bart, Orit
    Podoly, Tamar
    Bar-Haim, Yair
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2010, 31 (06) : 1443 - 1447
  • [24] Methylphenidate effects on EEG, behavior, and performance in boys with ADHD
    Swartwood, MO
    Swartwood, JN
    Lubar, JF
    Timmermann, DL
    Zimmerman, AW
    Muenchen, RA
    PEDIATRIC NEUROLOGY, 1998, 18 (03) : 244 - 250
  • [25] Effects of Methylphenidate on Acute Math Performance in Children With ADHD
    Jerome, Laurance
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (05): : 290 - 290
  • [26] Effects of vesperal methylphenidate (MPH) administration on diurnal and nocturnal activity in ADHD children:: An actigraphic study
    Konofal, E
    Lecendreux, M
    Bouvard, MP
    Mouren-Siméoni, MC
    SLEEP, 2001, 24 : A215 - A215
  • [27] The effectiveness of OROS® methylphenidate (Concerta®) vs. usual treatment with immediate-release methylphenidate (IR MPH) in children aged 6-12 years with attention deficit hyperactivity disorder (ADHD)
    Steele, M
    Riccardelli, R
    Binder, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S442 - S442
  • [28] Effects of methylphenidate and expectancy on children with ADHD: Behavior, academic performance, and attributions in a summer treatment program and regular classroom settings
    Pelham, WE
    Hoza, B
    Pillow, DR
    Gnagy, EM
    Kipp, HL
    Greiner, AR
    Waschbusch, DA
    Trane, ST
    Greenhouse, J
    Wolfson, L
    Fitzpatrick, E
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2002, 70 (02) : 320 - 335
  • [29] Effects of methylphenidate and physiotherapeutic treatment on graphomotor movements in children with ADHD
    Josefine Rothe
    Fabian A. Kattlun
    Jeanne Kaufmann
    Anne Uhlmann
    Sina Wanderer
    Annet Bluschke
    Christian Beste
    Veit Roessner
    European Child & Adolescent Psychiatry, 2024, 33 : 127 - 137
  • [30] Effects of methylphenidate and physiotherapeutic treatment on graphomotor movements in children with ADHD
    Rothe, Josefine
    Kattlun, Fabian A.
    Kaufmann, Jeanne
    Uhlmann, Anne
    Wanderer, Sina
    Bluschke, Annet
    Beste, Christian
    Roessner, Veit
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024, 33 (01) : 127 - 137
12345